MENU MENU

Event Details

Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer

02/13/24
10:30 AM EST

Webcast Presentation

Event Details
Title
Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer
Date / Time
02/13/24
10:30 AM EST

FibroGen Inc.

Volume:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor and Media Contact

  • Investors:
    David DeLucia, CFA
    Vice President, Corporate FP&A and Investor Relations
    ir@fibrogen.com

  • Media Inquiries:
    Simon Miller
    VP Commercial & External Communications
    media@fibrogen.com